The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy. [electronic resource]
Producer: 20170801Description: 4278-84 p. digitalISSN:- 1873-2518
- Antibodies, Viral -- blood
- Chickenpox Vaccine -- administration & dosage
- Enzyme-Linked Immunosorbent Assay
- Female
- Fever
- Healthy Volunteers
- Herpesvirus 3, Human -- immunology
- Humans
- Immunization Schedule
- Immunogenicity, Vaccine
- Infant
- Italy
- Male
- Measles virus -- immunology
- Measles-Mumps-Rubella Vaccine -- administration & dosage
- Meningococcal Infections -- prevention & control
- Meningococcal Vaccines -- administration & dosage
- Mumps virus -- immunology
- Rubella virus -- immunology
- Seroconversion
- Vaccines, Combined -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.